Christopher Dächert
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
-
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- SARS-CoV-2 detection and testing 4
-
- Respiratory viral infections research 2
- Co-authors
- Marco Binder (8 shared papers)Ralf Bartenschlager (4 shared papers)Pascal Mutz (2 shared papers)Thomas F. Baumert (1 shared paper)Stephan Urban (1 shared paper)Georgios Polychronidis (1 shared paper)Stefan Seitz (1 shared paper)Jamie Frankish (1 shared paper)
In The Last Decade
Christopher Dächert
15 papers receiving 262 citations
Peers
Comparison fields: 5 of 49
- Hepatology 83
- Epidemiology 118
- Infectious Diseases 61
- Virology 15
- Immunology 65
Countries citing papers authored by Christopher Dächert
This map shows the geographic impact of Christopher Dächert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Dächert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Dächert more than expected).
Fields of papers citing papers by Christopher Dächert
This network shows the impact of papers produced by Christopher Dächert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Dächert. The network helps show where Christopher Dächert may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Dächert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 126 | |
| 2 | 2020 | 35 | |
| 3 | 2022 | 22 | |
| 4 | 2021 | 18 | |
| 5 | 2022 | 9 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 7 | |
| 8 | 2019 | 7 | |
| 9 | 2024 | 7 | |
| 10 | 2022 | 6 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 1 | |
| 16 | 2025 | 0 |
About Christopher Dächert
Christopher Dächert is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Public Health, Environmental and Occupational Health and Hepatology, having authored 16 papers that have together received 263 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), SARS-CoV-2 detection and testing (4 papers), Mosquito-borne diseases and control (3 papers), Biosensors and Analytical Detection (3 papers), Hepatitis C virus research (3 papers), Respiratory viral infections research (2 papers), interferon and immune responses (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Hepatology (83 citations), Epidemiology (118 citations), Infectious Diseases (61 citations), Virology (15 citations) and Immunology (65 citations). Christopher Dächert has collaborated with scholars based in Germany, France and Austria. Frequent co-authors include Marco Binder, Ralf Bartenschlager, Pascal Mutz, Thomas F. Baumert, Stephan Urban, Georgios Polychronidis, Stefan Seitz, Jamie Frankish, Silke Bender and Philippe Metz. Their work appears in journals such as PLoS Computational Biology, Medical Microbiology and Immunology, Viruses, Nature Communications and Microbiology Spectrum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.